170 related articles for article (PubMed ID: 32994701)
81. The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer.
Kim YJ; Kim SS; Ahn SD; Jung J; Ahn SH; Son BH; Lee JW; Kim HJ; Ko BS; Kim SB; Jung KH; Ahn JH; Kim JE; Choi EK
Asia Pac J Clin Oncol; 2021 Dec; 17(6):495-505. PubMed ID: 33179406
[TBL] [Abstract][Full Text] [Related]
82. Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
Hotton J; Lusque A; Leufflen L; Campone M; Levy C; Honart JF; Mailliez A; Debled M; Gutowski M; Leheurteur M; Goncalves A; Jankowski C; Guillermet S; Bachelot T; Ferrero JM; Eymard JC; Petit T; Pouget N; de La Lande B; Frenel JS; Villacroux O; Simon G; Pons-Tostivint E; Marchai F
Ann Surg; 2023 Jan; 277(1):e153-e161. PubMed ID: 33534229
[TBL] [Abstract][Full Text] [Related]
83. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
84. Breast surgery for patients with de novo metastatic breast cancer: A meta-analysis of randomized controlled trials.
Ren C; Sun J; Kong L; Wang H
Eur J Surg Oncol; 2024 Jan; 50(1):107308. PubMed ID: 38048724
[TBL] [Abstract][Full Text] [Related]
85. DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases.
Budach W; Matuschek C; Bölke E; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Piroth MD; Sautter-Bihl ML; Sedlmayer F; Souchon R; Wenz F; Sauer R;
Strahlenther Onkol; 2015 Aug; 191(8):623-33. PubMed ID: 25963557
[TBL] [Abstract][Full Text] [Related]
86. Treatment strategy for de novo metastatic nasopharyngeal carcinoma: a literature review.
Liu Q; Li J; Ng WT; Lee AWM
Chin Clin Oncol; 2023 Aug; 12(4):43. PubMed ID: 37699604
[TBL] [Abstract][Full Text] [Related]
87. Surgical Management of Metastatic Breast Cancer: A Mini Review.
Ueno T
Front Oncol; 2022; 12():910544. PubMed ID: 35600412
[TBL] [Abstract][Full Text] [Related]
88. Could local surgery improve survival in de novo stage IV breast cancer?
Xiong Z; Deng G; Wang J; Li X; Xie X; Shuang Z; Wang X
BMC Cancer; 2018 Sep; 18(1):885. PubMed ID: 30200932
[TBL] [Abstract][Full Text] [Related]
89. Breast cancer after curative chemotherapy in non-Hodgkin's lymphoma: examination of the role of drug resistance and retrospective comparison to the outcome of de novo breast cancer.
Tsavaris N; Kosmas C; Zorzos H; Lazaris A; Vadiaka M; Dimitrakopoulos A; Siakantaris MP; Rokana S; Papalambros E; Pangalis GA; Davaris P
Oncol Rep; 2004 Apr; 11(4):899-903. PubMed ID: 15010892
[TBL] [Abstract][Full Text] [Related]
90. The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions.
Miyashita M; Balogun OB; Olopade OI; Huo D
Sci Rep; 2023 Feb; 13(1):2880. PubMed ID: 36804591
[TBL] [Abstract][Full Text] [Related]
91. Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer.
Bitencourt A; Rossi Saccarelli C; Morris EA; Flynn J; Zhang Z; Khan A; Gillespie E; Cahlon O; Mueller B; Cuaron JJ; McCormick B; Powell SN; Plitas G; Razavi P; Pinker K; Riedl CC; Sutton EJ; Braunstein LZ
JAMA Netw Open; 2020 Oct; 3(10):e2018790. PubMed ID: 33034638
[TBL] [Abstract][Full Text] [Related]
92. Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer.
Kim BH; Kim S; Kim YI; Chang JH; Hwang KT; Kim S; Cho MJ; Kwon J
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751136
[TBL] [Abstract][Full Text] [Related]
93. Breast cancer under age 40: a different approach.
Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
[TBL] [Abstract][Full Text] [Related]
94. Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis.
Wang X; Liang N; Tian T; Zhang J; Hu P
Technol Cancer Res Treat; 2022; 21():15330338221089937. PubMed ID: 35491730
[No Abstract] [Full Text] [Related]
95. Treatment with Granulocyte-colony Stimulating Factor (G-CSF) is not associated with Increased Risk of Brain Metastasis in Patients with
Fujii T; Rehman H; Chung SY; Shen J; Newman J; Wu V; Hines A; Azimi-Nekoo E; Fayyaz F; Lee M; Raptis G; Egeblad M; Zhu X
J Cancer; 2021; 12(18):5687-5692. PubMed ID: 34405029
[No Abstract] [Full Text] [Related]
96. Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer: A Single-Institution Retrospective Analysis from China.
Cai SL; Wang ZH; Chen XG; Han L; Gong GX; Chen YP; Lin XQ; Ma T; Chen HD
Front Oncol; 2022; 12():905065. PubMed ID: 35832552
[TBL] [Abstract][Full Text] [Related]
97. Risk factors for stage IV breast cancer at the time of presentation in Turkey.
Uyeturk U; Tatli AM; Gucuk S; Oksuzoglu B; Ulas A; Avci N; Ozbay MF; Gunduz S; Akinci MB; Salim DK; Sonmez OU; Akdag F; Ergenc H
Asian Pac J Cancer Prev; 2013; 14(12):7445-9. PubMed ID: 24460317
[TBL] [Abstract][Full Text] [Related]
98. Locoregional therapy in de novo metastatic breast cancer. The unanswered question.
Cardoso MJ; Mokbel K
Breast; 2021 Aug; 58():170-172. PubMed ID: 34158166
[No Abstract] [Full Text] [Related]
99. Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China.
Ma L; Mi Y; Cui S; Wang H; Fu P; Yin Y; Jin F; Li J; Liu Y; Fan Z; Zhang H; Geng C; Jiang Z
Sci Rep; 2020 Oct; 10(1):18132. PubMed ID: 33093581
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
